Picture of IRLAB Therapeutics AB logo

IRLAB A — IRLAB Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Irlab Therapeutics Says No Dividend Shall Be Paid For Past Financial Year

May 7 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * REPORT FROM THE ANNUAL GENERAL MEETING OF IRLAB
THERAPEUTICS AB
    * IRLAB THERAPEUTICS AB - DISPOSITION OF COMPANY'S RESULTS
PROPOSED BY BOARD WAS ADOPTED BY ANNUAL GENERAL MEETING
    * IRLAB THERAPEUTICS - AMOUNT AVAILABLE TO AGM, TOTALING SEK
420,888,103, BE TRANSFERRED IN FULL,THAT NO DIVIDEND SHALL BE
PAID FOR PAST FINANCIAL YEAR
    * IRLAB THERAPEUTICS - AGMRESOLVED TO DISCHARGE BOARD
MEMBERS,MANAGING DIRECTOR FROM LIABILITY FOR THEIR
ADMINISTRATION DURING FINANCIAL YEAR 2019
    * IRLAB THERAPEUTICS AB - LARS ADLERSSON, CAROLA LEMNE, EVA
LINDGREN, GUNNAR OLSSON, REIN PIIR AND LENA TORLEGÅRD WERE
RE-ELECTED AS BOARD MEMBERS
    * IRLAB THERAPEUTICS AB - GUNNAR OLSSON WAS ELECTED AS NEW
CHAIRMAN OF BOARD AND CAROLA LEMNE WAS RE-ELECTED AS DEPUTY
CHAIRMAN OF BOARD
    * IRLAB THERAPEUTICS AB - FIRM OF AUDITORS ÖHRLINGS
PRICEWATERHOUSECOOPERS AB WAS ELECTED AS AUDITOR OF COMPANY WITH
JOHAN RIPPE AS PRINCIPAL AUDITOR

Source text for Eikon:  ID:nWkr11Dl9t 
Further company coverage:  IRLABa.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IRLAB Therapeutics AB

See all news